21
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39966 |
SGLT1/2-IN-2
SGLT1/2-IN-2 |
||
SGLT1/2-IN-2 is a chemical compound with robust dual inhibitory properties, exhibiting potent activities against SGLT1 (IC50 = 96 nM) and SGLT2 (IC50 = 1.3 nM). | |||
T62830 |
SGLT1/2-IN-1
|
||
SGLT1/2-IN-1 是一种 SGLT1/SGLT2 双重抑制剂. | |||
T9590 |
T-1095
|
SGLT; transporter | GPCR/G Protein; Metabolism |
T-1095 是一种口服有活性的Na+-葡萄糖协同转运蛋白选择性抑制剂,能够抑制 SGLT1 (IC50:22.8 µm) 及 SGLT2 (IC50:2.3 µm) 。它可用于研究糖尿病。 | |||
T15656 |
KGA-2727
|
SGLT | GPCR/G Protein |
KGA-2727是选择性,高亲和力和口服有效的 SGLT1抑制剂,对人和大鼠 SGLT1的 Ki 分别为 97.4 nM 和 43.5 nM,对 SGLT1的选择性比人SGLT2 高 140 倍 ,大鼠SGLT2高390 倍。KGA-2727具有抗糖尿病活性。 | |||
T16083 |
Mizagliflozin
GSK-1614235 free base,KGA-3235 free base,DSP-3235 free base |
SGLT | GPCR/G Protein |
Mizagliflozin (GSK-1614235 free base) 是口服有效的、选择性的 SGLT1抑制剂,对人 SGLT1 的 Ki 值为 27 nM。Mizagliflozin 对 SGLT1 的选择性是 SGLT2的303 倍。它是抗糖尿病药物,可以改善餐后血糖波动。它在改善慢性便秘方面具有潜在的作用。 | |||
T3547 |
Sotagliflozin
LX-4211,LP-802034 |
SGLT | GPCR/G Protein |
Sotagliflozin (LP-802034) 是有效的SGLT1/2抑制剂,用作抗糖尿病剂。 | |||
T8753 |
LX-2761 intermediate
|
Others | Others |
LX-2761 intermediate 是LX-2761的合成中间体。LX-2761是一种化学稳定且有效的SGLT1/2抑制剂。 | |||
T8750 |
LX-4211 intermediate
|
Others | Others |
LX-4211 intermediate 是LX-4211的合成中间体。LX-4211是有效的SGLT1/2抑制剂,用作抗糖尿病剂。 | |||
T2385 |
Ipragliflozin
伊格列净,ASP1941 |
SGLT | GPCR/G Protein |
Ipragliflozin (ASP1941) 是一种口服有效的,选择性的 SGLT2抑制剂,对人 SGLT2 和 SGLT1,大鼠 SGLT2 和 SGLT1,小鼠 SGLT2 和 SGLT1 的 IC50分别为 7.38 和 1876 nM,6.73 和 1166 nM,5.64 和 1380 nM。Ipragliflozin 具有抗糖尿病活性。 | |||
T7217 |
Bexagliflozin
THR-1442,EGT1442,EGT0001442 |
SGLT | GPCR/G Protein |
Bexagliflozin (EGT1442) 是一种选择性的,口服有效的钠葡萄糖协同转运蛋白-2 (SGLT2) 抑制剂,对人 SGLT2 和 SGLT1 作用的 IC50值分别为 2 nM 和 5.6 μM。EGT1442在 2 型糖尿病中有研究价值。 | |||
T1782L |
Canagliflozin hemihydrate
JNJ28431754,TA 7284,TA7284,TA-7284,JNJ 28431754,JNJ-28431754 |
SGLT | GPCR/G Protein |
Canagliflozin hemihydrate (TA 7284) (JNJ28431754 hemihydrate) 是一种选择性的 SGLT2 抑制剂,作用于表达 mSGLT2,rSGLT2 和 hSGLT2 的 CHO 细胞,IC50 分别为 2 nM,3.7 nM 和 4.4 nM。 | |||
T15797 |
LX2761
|
Others | Others |
LX2761 is a chemically stable and effective inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 (IC50s: 2.2 nM and 2.7nM for hSGLT1 and hSGLT2). However, it shows specific SGLT1 inhibition in the gastrointestinal (GI) tract. | |||
T12892 |
SGL5213
|
SGLT | GPCR/G Protein |
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. | |||
T34286 |
Remogliflozin etabonate
GSK189075,GSK 189075,GSK-189075A,GSK189075A,GSK-189075,GSK 189075A |
SGLT | GPCR/G Protein |
Remogliflozin etabonate (GSK189075A) 是 regaliflozin 的前药和 SGLT2 抑制剂,对 hSGLT2、rSGLT2、rSGLT1 和 hSGLT1 的 Ki 值分别为 1.95、2.14、8.57 和 43.1μM。 | |||
T15752 |
Licogliflozin
LIK066 |
SGLT | GPCR/G Protein |
Licogliflozin (LIK066) 是钠-葡萄糖协同转运蛋白 (SGLT1和SGLT2) 的有效抑制剂。 | |||
T32058 |
Henagliflozin
SHR3824,SHR 3824,SHR-3824 |
||
Henagliflozin (SHR3824) is an effective, oral, and selective SGLT2 inhibitor that effectively inhibits human SGLT2 in vitro, but has very weak inhibitory effects on human SGLT1. | |||
T28659 |
SAR-7226 Hydrate
SAR7226,SAR 7226,SAR-7226 |
||
SAR-7226 Hydrate, a SGLT1/2 inhibitor, is used potentially for the treatment of type 2 diabetes. | |||
T68236 |
TP0438836
|
||
TP0438836 is a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor for the treatment of type 2 diabetes. TP0438836 showed IC50 values 28nM and 7 nM for hSGLT1 and hSGLT2 resepctively. | |||
T11667 |
Ipragliflozin (L-Proline)
Ipragliflozin L-Proline |
Others | Others |
Ipragliflozin is a highly potent and selective SGLT2 inhibitor with an IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6. | |||
T71340 | Mizagliflozin sebacate | ||
Mizagliflozin sebacate is a sodium-glucose transporter inhibitor. It is expected to improve postprandial hyperglycemia by suppressing glucose absorption from the intestine with a novel mechanism of action different from that of conventional alpha-glucosidase inhibitors. Mizagliflozin blocks intestinal glucose absorption and reduce GIP secretion in rats and humans, suggesting SGLT1 glucose transport is critical for GIP release. | |||
T12893 |
SGLT inhibitor-1
|
SGLT | GPCR/G Protein |
SGLT inhibitor-1 is a potentsodium glucose co-transporter proteins (SGLTs) dual inhibitor(hSGLT1 and hSGLT2 with IC50s of 43 nM and 9 nM, respectively). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2S0731 |
Trilobatin
三叶苷,三叶甙,P-Phlorizin |
Amylase | Metabolism |
Trilobatin (P-Phlorizin) 是源自Lithocarpus polystachyusRehd 的甜味剂,是一种HIV-1抑制剂,靶向 Gp41 包膜蛋白,具有神经保护作用。它还是SGLT1/2抑制剂,可选择性诱导人肝母细胞瘤细胞增殖。 | |||
T2922 |
Phlorizin
Floridzin,根皮甙,根皮苷,NSC 2833,Phloridzin |
ATPase; SGLT | GPCR/G Protein; Membrane transporter/Ion channel |
Phlorizin (Phloridzin) 是非选择性的SGLT 抑制剂,也是Na+/K+-ATPase 抑制剂,对于hSGLT1和hSGLT2的Ki 值分别为 300 和 39 nM。 |